JCAD and metabolic dysfunction-associated steatohepatitis: Similarly, fatty acid overload in hepatic cells of a NASH mouse model upregulated the obesity-associated junctional cadherin 5 associated protein (JCAD) that in turn inhibited LATS2 prompting YAP-mediated progression to liver cancer [69].